The REVAMP trial: key questions remain - Authors' reply

Lancet. 2024 Jan 6;403(10421):29-30. doi: 10.1016/S0140-6736(23)01915-3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Kommentar